Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-9-13
pubmed:abstractText
Although mortality rates among HIV-infected populations have declined with the advent of combination antiretroviral therapy (ART), patients with substance use disorders have benefited less from these therapies. While adherence to ART has been well studied, less is known about factors associated with discontinuation of ART. The aim of this study is to investigate predictors of discontinuation of ART in HIV-infected patients with alcohol problems, focusing on their substance use and depressive symptoms. The study cohort (n=266) was prospectively assessed with biannual standardised interviews between 2001 and 2005. Four predictor variables (cocaine, heroin, heavy alcohol use and substantial depressive symptoms) were assessed six months prior to the outcome (ART discontinuation). Longitudinal logistic regression models examined the association between predictor variables and ART discontinuation adjusting for age, gender, race/ethnicity, homelessness, CD4, HIV RNA and HIV Symptom Index. Subjects were 77% male; 43% black; 22% homeless; 45% used cocaine; 20% used heroin; 29% had heavy alcohol use; and 40% had substantial depressive symptoms. Discontinuation occurred in 135 (17%) of the observations (n=743). In bivariate analyses, cocaine use, heroin use and depressive symptoms were significantly associated with ART discontinuation but heavy alcohol use was not. In the multivariable model, substantial depressive symptoms (adjusted odds ratio (AOR)=1.66; 95% confidence interval (CI): 1.04, 2.65) but not cocaine (AOR=1.28; 95%CI: 0.76, 2.16) or heroin use (AOR=1.27 95%CI: 0.66, 2.44), remained significantly associated with ART discontinuation. Among HIV-infected adults with alcohol problems, depressive symptoms, but not substance use, predicted subsequent ART discontinuation. Recognition and treatment of depressive symptoms in this population may result in better maintenance of ART and its associated clinical benefits.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-10924648, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-11285657, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-11483137, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-11684929, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-11750213, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-11953472, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12033694, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12133141, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12215078, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12394800, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12745413, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12823652, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-12869842, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15018702, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15136661, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15226133, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15259903, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15289279, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15671804, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15735452, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15764957, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15764968, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15908852, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-15989457, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16036240, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16055769, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16256278, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16338766, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16394200, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16494629, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-16566620, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-1929025, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-2848472, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-3233245, http://linkedlifedata.com/resource/pubmed/commentcorrection/17852002-7618986
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0954-0121
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1039-47
pubmed:dateRevised
2010-8-9
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems.
pubmed:affiliation
Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston University, School of Medicine, Boston, MA, USA. theresa.kim@bmc.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Research Support, N.I.H., Extramural